Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca B Riggins

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Bioinformatics (Oxford, England)|May 19, 2012
Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statisticJinghua Gu, Jianhua Xuan, Rebecca B Riggins, et al.
Advanced Healthcare Materials|July 20, 2024
Acquired Temozolomide Resistance Instructs Patterns of Glioblastoma Behavior in Gelatin HydrogelsVictoria A Kriuchkovskaia, Ela K Eames, Rebecca B Riggins, et al.
Breast Cancer Research and Treatment|August 22, 2009
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancerLuciane R Cavalli, Rebecca B Riggins, Antai Wang, et al.
Plos One|January 30, 2023
ROS is a master regulator of in vitro matriptase activationDarius O Gaymon, Robert Barndt, Hillary Stires, et al.
International Journal of Computational Biology and Drug Design|January 9, 2010
Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysisLi Chen, Jianhua Xuan, Yue Wang, et al.
Tissue Engineering. Part C, Methods|March 16, 2026
The Size of Glioblastoma Spheroids Influences Patterns of Invasion and Temozolomide EfficacySheridan Fok, Anagha Shreesha, Angela Appiah-Kubi, et al.
NPJ Systems Biology and Applications|July 3, 2025
Personalized cancer treatment strategies incorporating irreversible and reversible drug resistance mechanismsWei He, Matthew D McCoy, Rebecca B Riggins, et al.
Bioinformatics (Oxford, England)|April 9, 2010
Multilevel support vector regression analysis to identify condition-specific regulatory networksLi Chen, Jianhua Xuan, Rebecca B Riggins, et al.
Molecular Cancer Therapeutics|May 12, 2010
IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosisYanxia Ning, Rebecca B Riggins, Jennifer E Mulla, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|January 11, 2014
Reconstruction of transcriptional regulatory networks by stability-based network component analysisXi Chen, Jianhua Xuan, Chen Wang, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Bioinformatics (Oxford, England)|May 19, 2012
Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statisticJinghua Gu, Jianhua Xuan, Rebecca B Riggins, et al.
Advanced Healthcare Materials|July 20, 2024
Acquired Temozolomide Resistance Instructs Patterns of Glioblastoma Behavior in Gelatin HydrogelsVictoria A Kriuchkovskaia, Ela K Eames, Rebecca B Riggins, et al.
Breast Cancer Research and Treatment|August 22, 2009
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancerLuciane R Cavalli, Rebecca B Riggins, Antai Wang, et al.
Plos One|January 30, 2023
ROS is a master regulator of in vitro matriptase activationDarius O Gaymon, Robert Barndt, Hillary Stires, et al.
International Journal of Computational Biology and Drug Design|January 9, 2010
Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysisLi Chen, Jianhua Xuan, Yue Wang, et al.
Tissue Engineering. Part C, Methods|March 16, 2026
The Size of Glioblastoma Spheroids Influences Patterns of Invasion and Temozolomide EfficacySheridan Fok, Anagha Shreesha, Angela Appiah-Kubi, et al.
NPJ Systems Biology and Applications|July 3, 2025
Personalized cancer treatment strategies incorporating irreversible and reversible drug resistance mechanismsWei He, Matthew D McCoy, Rebecca B Riggins, et al.
Bioinformatics (Oxford, England)|April 9, 2010
Multilevel support vector regression analysis to identify condition-specific regulatory networksLi Chen, Jianhua Xuan, Rebecca B Riggins, et al.
Molecular Cancer Therapeutics|May 12, 2010
IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosisYanxia Ning, Rebecca B Riggins, Jennifer E Mulla, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|January 11, 2014
Reconstruction of transcriptional regulatory networks by stability-based network component analysisXi Chen, Jianhua Xuan, Chen Wang, et al.
Pageof 8